Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Molecular and Cellular Biochemistry|January 9, 2026
Advances in the application of spatial transcriptomics in understanding development and diseaseYao Li, Qian-Wen Zheng, Mingpeng Li, et al.Nature Communications|March 23, 2025
Mitochondria transplantation transiently rescues cerebellar neurodegeneration improving mitochondrial function and reducing mitophagy in miceShu-Jiao Li, Qian-Wen Zheng, Jie Zheng, et al.Toxins|November 25, 2021
Ochratoxin A Induces Steatosis via PPARγ-CD36 AxisQian-Wen Zheng, Xu-Fen Ding, Hui-Jun Cao, et al.Oncogene|July 11, 2021
Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axisEr-Bin Zhang, Xiuping Zhang, Kang Wang, et al.Cell Reports|April 7, 2023
PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1Yi-Kang Wang, Ning Ma, Sheng Xu, et al.Cell Death and Differentiation|November 17, 2022
ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2Hui-Jun Cao, Hao Jiang, Kai Ding, et al.Oncogene|July 29, 2022
PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3Qian-Wen Zheng, Qian-Zhi Ni, Bing Zhu, et al.Cellular and Molecular Gastroenterology and Hepatology|April 7, 2022
Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular CarcinomaFeng-Kun Zhang, Qian-Zhi Ni, Kang Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axisHao Jiang, Hui-Jun Cao, Ning Ma, et al.Journal for Immunotherapy of Cancer|August 7, 2025
PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axisBing Zhu, Ning Ma, Zhi-Chao Liu, et al.Pageof 2